stock logo

50% Buy

Biocon Share Price

BIOCON

₹380.05+₹4.80 (1.28%) TodayLast updated on 06 Dec, 2024 | 15:59 IST

Biocon Share Price Chart

Please wait...
  • About Biocon
  • Fundamentals
  • Events
  • F&O (Option chain)
  • More
  • News

About Biocon

Biocon Financials

arrow
Market cap
Market Cap Switch₹45,517 Crs
Open
₹376.50
Close
₹375.25
Circuit range
₹418.05 - ₹342.05
Day range
₹372.75 - ₹381.50
Year range
₹236.90 - ₹395.80
Volume
22,46,090
Avg. traded
₹378.71
Revenue (12m)
₹14,894 Crs
Biocon

Biocon India Pvt Ltd is a biotechnology company engaged in all phases of the product cycle from the discovery to the development and commercialisation of the drug.

The company was incorporated as a joint venture between Kiran Mazumdar-Shaw and Biocon Biochemicals Ltd Ireland in 1978. The company started in Bengaluru with just three employees. It began manufacturing and exporting papain, a plant enzyme, and isinglass, a marine hydrocolloid – both key products for the brewing industry.

Two years later, Biocon laid the foundation of its campus in Bengaluru to expand its operation. The building to date is home to the company's corporate office. In 1984, a year after the construction of the company's head office, Biocon established its R&D division, which initially focused on the development of solid-state fermentation technology to develop novel enzymes.

In 1989, Biocon Biochemicals Ltd, Ireland, along with its subsidiaries was acquired by Unilever plc and merged with its wholly-owned subsidiary Quest International. This paved the way for Biocon India to produce enzymes for Unilever’s food businesses.

Business operations

Biocon India became the first life science company in the country to get ISO 9001 Certification. The company incorporated Syngene as a custom research organisation (CRO) in 1994 to provide efficient, high-quality, cost-effective research and development services in chemistry and biology.

In 1998, Biocon became an independent company after Kiran Mazumdar-Shaw and John Shaw bought Unilever’s share in the company.

At the turn of the century, Biocon established Clinigene as India's first clinical research organisation.

In 2002, Biocon established a joint venture company, Biocon Biopharmaceuticals Pvt Ltd, with CIMAB S.A., a Cuban biotechnology company.

Biocon went public with a successful IPO in 2004. On the day of the listing, the company crossed a market value of $1.1 billion, making Biocon only the second Indian company to do so.

In 2006, the company inaugurated Biocon Park, India's first biotechnology special economic zone (SEZ).

Biocon divested its legacy enzymes business to Novozymes for $115 million in 2007 to increase focus on developing, and manufacturing biopharmaceuticals.

Biocon launched Insulin Glargine under the brand name Basalog in India in 2009, offering diabetes patients an advanced, affordable insulin therapy. The company’s research organisation, Syngene made a debut on the Indian stock market in 2015.

Biocon Biologics approved a primary equity investment by True North in 2020. The same year, Tata Capital picked up a minority stock in Biocon Biologics. Biocon Biologics also received a $150 million capital injection from Goldman Sachs.

Biocon's market capitalisation stands at over ₹30,399 crore as of December 20, 2023. Biocon Ltd's share price has plunged over 47% in the last three years.

Financial Highlights

The total income of the company for FY23 stood at ₹11,550 crore, up by 38% year-on-year. The firm reported a profit of ₹462.7 crore in FY23. The EBITDA (earnings before interest, taxes, depreciation and amortisation) stood at ₹2,887.6 crore in FY23. The EBITDA margin stood at 25% in FY23. The company made a total capital expenditure of ₹530 crore in FY23. Its earnings per share (EPS) increased to ₹3.9 in FY23.

Biocon Key indicators

arrow
52 week high
₹395.80
52 week low
₹236.90
P/E ratio
31.61
P/B ratio
2.17
ROE
1.1%
ROCE
2.77%
Dividend yield
0.13%
Debt/Equity ratio
0.19
EPS
0.99

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

50%

Hold

12%

Sell

38%

This analysis is based on the reviews of 16 experts in the last 7 days

Biocon Fundamentals

Biocon Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

21.42%

Net profit margin

5.61%

ROE

1.1%

ROA

0.89%

ROCE

2.77%

Learn more

Biocon Shareholder returns

arrow
1 day
+1.28%
1 week
+4.08%
1 month
+17.72%
3 months
+1.70%
1 year
+58.09%
3 years
+5.64%
5 years
+31.51%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
  • Revenue

  • Operating profit

  • Net profit

Learn more

Cash flow

All values are in ₹ Crores (Cr)
arrow
  • Operating

  • Investing

  • Financing

Learn more

Balance sheet

All values are in ₹ Crores (Cr)
arrow

Total assets

Total liabilities

Learn more

Biocon Share Price history

arrow
DayOpenCloseChange %
Fri, Dec 6 2024
₹376.50
₹380.05
+1.28%
Thu, Dec 5 2024
₹380.00
₹375.25
-1.17%
Wed, Dec 4 2024
₹373.90
₹379.70
+1.56%
Tue, Dec 3 2024
₹374.45
₹373.85
-0.40%
Mon, Dec 2 2024
₹375.00
₹375.35
+2.79%
Fri, Nov 29 2024
₹361.40
₹365.15
+0.33%
Thu, Nov 28 2024
₹360.00
₹363.95
+1.48%
Wed, Nov 27 2024
₹354.00
₹358.65
+1.70%

Biocon Shareholding Pattern

arrow

Promoters (60.64%)

Mutual Funds (7.97%)

Retail and other (18.99%)

Foreign institutions-FII (5.93%)

Other domestic institutions (6.47%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹0.5/share

    Ex date 05 Jul 2024

    expand tab
  • Dividend • ₹1.5/share

    Ex date 07 Jul 2023

    expand tab
  • Dividend • ₹0.5/share

    Ex date 30 Jun 2022

    expand tab

Learn more

FAQs on Biocon

What is the Biocon share price today?

chevron-up
Biocon share price is ₹ 380.05 today.

What is today’s high & low share price of Biocon?

chevron-up
Biocon share price high: ₹ 381.50 and low: ₹ 372.75

What is the Biocon share price high and low in the last 52 weeks on the NSE?

chevron-up
52 Week share High Price is ₹ 395.80 and Low Price is ₹ 236.90

What is the Biocon Stock Symbol?

chevron-up
The Biocon Stock symbol is BIOCON.

Can I buy Biocon shares on Holidays?

chevron-up
No, shares of Biocon or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Biocon shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.